October 24, 2013 – PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 24, 2013
October 2, 2013 — Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol ...
October 02, 2013Oct. 1, 2013 – The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report ...
October 01, 2013September 30, 2013—A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per ...
September 30, 2013
September 26, 2013 — Lead study investigators from Icahn School of Medicine at Mount Sinai presented their Patterns of ...
September 26, 2013September 23, 2013 – Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the ...
September 23, 2013September 18, 2013 — Decision Resources forecasts that Bayer/Janssen's Xarelto will be the sales-leading therapy among ...
September 18, 2013September 13, 2013 — Atherotech Diagnostics Lab has added three new genetic tests to its cardiometabolic test offering ...
September 13, 2013September 9, 2013 -- Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme ...
September 09, 2013September 5, 2013 — Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with ...
September 05, 2013September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing, announced ...
September 05, 2013August 5, 2013 — AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence ...
August 05, 2013
July 25, 2013 — Merck announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine ...
July 25, 2013July 22, 2013 — T2 Biosystems announced the presentation of data strongly correlating T2Hemostat results with patients’ ...
July 22, 2013July 15, 2013 — Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) has issued a ...
July 15, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now